Biogen Inc.

NAS: BIIB
Pharmaceuticals
Cambridge MA
Title 1Chairman
Executive 1Dr. Stelios Papadopoulos, Ph.D., Chairman | Chairman
2015 Revenue (US$ Millions)$10,764
2014 Revenue (US$ Millions)$9,703
Revenue Growth (%)10.93%
Net Income (US$ Millions)$3,547
Common Shares Outstanding (Millions)$219
Earnings Per Share (US$)$15.34
Price To Earnings Ratio30.95
Total Equity (US$ Millions)$9,373
Return On Equity (%)32.82%
Long Term Debt (US$ Millions)$6,522
Debt To Equity Ratio (%)0.70%
Market Capitalization (US$ Millions)$66,968
Total Assets (US$ Millions)$19,505
Current Assets (US$ Millions)$6,700
Inventories (US$ Millions)$893
Current Liabilities (US$ Millions)$2,578
Cost of Goods Sold (US$ Millions)$1,240
Asset Turnover0.55
Inventory Turnover1.46